NOVAVAX INC Other Current Assets
NOVAVAX INC (NVAX) had Other Current Assets of $9.87 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-02-26
- 2025-12-31: Other Assets, Current $9.87M.
- 2024-12-31: Other Assets, Current $21.89M.
- 2023-12-31: Other Assets, Current $155.73M.
- 2022-12-31: Other Assets, Current $76.37M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $9.87M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $21.89M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $155.73M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $76.37M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $44.62M 10-K · filed 2023-02-28 | $53.49M 10-K · filed 2022-03-01 |
| 2020-12-31 | $9.66M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $4.38M 10-K · filed 2021-03-01 | $3.60M 10-K · filed 2020-03-11 |
| 2018-12-31 | $4.32M 10-K · filed 2020-03-11 | |
| 2017-12-31 | $4.69M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $6.30M 10-K · filed 2018-03-14 | $6.07M 10-K · filed 2017-02-27 |
| 2015-12-31 | $6.35M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $1.63M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $402.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $269.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $504.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.86M 10-K · filed 2015-02-27 | $573.00K 10-K · filed 2014-03-12 |
| 2013-09-30 | $365.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $20.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $886.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $171.00K 10-K · filed 2014-03-12 | |
| 2012-09-30 | $235.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $261.00K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $177.00K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $1.56M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $392.00K 10-Q · filed 2011-11-08 | |
| 2010-12-31 | $265.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |